MAPT and early-onset autosomal dominant Alzheimer disease: Alzheimer’s disease (AD) is a debilitating neurodegenerative condition characterized by the presence of extracellular amyloid-β (Aβ) plaques, intracellular tau-containing neurofibrillary tangles (NFTs), neurodegeneration, and cognitive impairment [1, 2].